(Reuters) - The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention are investigating a ...
Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after ...
The FDA has approved Rapiblyk, a new drug to treat irregular heartbeats in critically ill hospitalized patients with severe ...
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Given how the U.S. Supreme Court’s conservative majority is better known for limiting the authority of federal regulatory ...
Products sold in the Northwest have been given the highest risk status, but so far no illnesses have been reported.
Despite hotly debated biomarkers and failed or delayed confirmatory trials, the accelerated approval program has a track ...